Healthcare provider profile · identity verified

Dan C Powell, MD

Allopathic & Osteopathic Physicians|Family Medicine · SAN ANTONIO, TX · NPI 1912921701

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Dan C Powell, MD received $16.97 in general payments during 2025 across 1 reported records.

GE HEALTHCARE accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$16.97

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
GE HEALTHCARE	Unresolved — no canonical attribution shown	$16.97	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$16.97	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	707	222
Atorvastatin Calcium	Atorvastatin Calcium	437	126
Losartan Potassium	Losartan Potassium	406	129
Levothyroxine Sodium	Levothyroxine Sodium	400	123
Lisinopril	Lisinopril	341	114
Amlodipine Besylate	Amlodipine Besylate	326	101
Pantoprazole Sodium	Pantoprazole Sodium	248	91
Montelukast Sodium	Montelukast Sodium	199	69
Metformin Hcl	Metformin Hcl	184	57
Metoprolol Succinate	Metoprolol Succinate	184	56
Trazodone Hcl	Trazodone Hcl	177	58
Pravastatin Sodium	Pravastatin Sodium	169	56
Simvastatin	Simvastatin	159	43
Meloxicam	Meloxicam	155	49
Fluticasone Propionate	Fluticasone Propionate	154	69
Omeprazole	Omeprazole	147	53
Tamsulosin Hcl	Tamsulosin Hcl	134	49
Hydrochlorothiazide	Hydrochlorothiazide	133	45
Telmisartan	Telmisartan	132	41
Escitalopram Oxalate	Escitalopram Oxalate	131	50
Tizanidine Hcl	Tizanidine Hcl	122	50
Ozempic	Semaglutide	119	23
Gabapentin	Gabapentin	118	36
Glipizide Er	Glipizide	116	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	21
Metformin Hcl Er	Metformin Hcl	108	34
Duloxetine Hcl	Duloxetine Hcl	101	24
Albuterol Sulfate Hfa	Albuterol Sulfate	98	48
Alendronate Sodium	Alendronate Sodium	97	30
Metoprolol Tartrate	Metoprolol Tartrate	95	28
Zolpidem Tartrate	Zolpidem Tartrate	95	30
Allopurinol	Allopurinol	92	28
Famotidine	Famotidine	84	29
Furosemide	Furosemide	84	34
Carvedilol	Carvedilol	82	28
Tramadol Hcl	Tramadol Hcl	82	22
Potassium Chloride	Potassium Chloride	81	27
Clopidogrel	Clopidogrel Bisulfate	80	28
Bupropion Xl	Bupropion Hcl	78	28
Finasteride	Finasteride	76	20
Pregabalin	Pregabalin	74	23
Farxiga	Dapagliflozin Propanediol	69	12
Donepezil Hcl	Donepezil Hcl	68	17
Buspirone Hcl	Buspirone Hcl	65	19
Hydroxyzine Hcl	Hydroxyzine Hcl	65	31
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	61	23
Eliquis	Apixaban	58	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	56	20
Enalapril Maleate	Enalapril Maleate	55	18
Prednisone	Prednisone	55	34
Oxybutynin Chloride	Oxybutynin Chloride	52	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	17
Paroxetine Hcl	Paroxetine Hcl	49	18
Mounjaro	Tirzepatide	48	suppressed
Alprazolam	Alprazolam	45	12
Irbesartan	Irbesartan	43	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	16
Synthroid	Levothyroxine Sodium	42	suppressed
Ezetimibe	Ezetimibe	41	12
Hydralazine Hcl	Hydralazine Hcl	40	13
Hydrocortisone	Hydrocortisone	40	19
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	37	11
Atenolol	Atenolol	36	13
Chlorthalidone	Chlorthalidone	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	12
Clonazepam	Clonazepam	33	suppressed
Valsartan	Valsartan	33	suppressed
Baclofen	Baclofen	32	11
Estradiol	Estradiol	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	14
Ibuprofen	Ibuprofen	32	12
Ondansetron Hcl	Ondansetron Hcl	32	20
Propranolol Hcl	Propranolol Hcl	32	13
Cefdinir	Cefdinir	31	29
Glipizide	Glipizide	31	suppressed
Jardiance	Empagliflozin	31	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Methocarbamol	Methocarbamol	30	12
Ramipril	Ramipril	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	14
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Folic Acid	Folic Acid	25	suppressed
Ondansetron Odt	Ondansetron	25	15
Risperidone	Risperidone	25	suppressed
Eszopiclone	Eszopiclone	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	14
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	19
Ciclopirox	Ciclopirox	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Nystatin	Nystatin	21	16
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Promethazine Hcl	Promethazine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Valacyclovir	Valacyclovir Hcl	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Ketoconazole	Ketoconazole	17	11
Nitroglycerin	Nitroglycerin	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Fluconazole	Fluconazole	16	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	13
Mometasone Furoate	Mometasone Furoate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Topiramate	Topiramate	15	suppressed
Diclofenac Potassium	Diclofenac Potassium	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Linzess	Linaclotide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Levofloxacin	Levofloxacin	12	11
Memantine Hcl	Memantine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Emgality Syringe	Galcanezumab-Gnlm	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$16.97 · 1 records	GE HEALTHCARE	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error